Table 4 Risk of all-cause mortality according to use of prophylaxis-dose aspirin or NSAIDs after diagnosis

From: Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study

Pre-diagnosis exposure strata

Aspirin non-user, HR

Low-dose aspirin user, HR

(95% CI)

NSAID non-user, HR

Low-dose NSAID user, HR

(95% CI)

All participants

      

 Deaths/number remaining alive

4400/6925

772/1441

 

3914/6319

982/1693

 

 Age-adjusted HR

1 (Ref)

0.91

(0.84, 0.98)

1 (Ref)

0.94

(0.87, 1.01)

 Age and pre-diagnosis drug use adjusted HR

1 (Ref)

0.86

(0.79, 0.94)

1 (Ref)

0.94

(0.87, 1.01)

 Multivariate HRa

1 (Ref)

0.89

(0.8, 0.98)

1 (Ref)

0.94

(0.86, 1.02)

Aspirin/NSAID non-users pre-diagnosis

      

 Deaths/number remaining alive

3910/6231

175/265

 

2391/3671

157/171

 

 Age-adjusted HR

1 (Ref)

0.97

(0.83, 1.13)

1 (Ref)

1.21

(1.03, 1.42)

 Multivariate HRa

1 (Ref)

0.99

(0.84, 1.16)

1 (Ref)

1.25

(1.04, 1.49)

Aspirin/NSAID users pre-diagnosis

 Deaths/number remaining alive

490/694

597/1176

 

1523/2648

825/1522

 

 Age-adjusted HR

1 (Ref)

0.81

(0.72, 0.92)

1 (Ref)

0.89

(0.81, 0.97)

 Multivariate HRa

1 (Ref)

0.83

(0.73, 0.95)

1 (Ref)

0.88

(0.8, 0.96)

  1. Abbreviations: CI=confidence interval; HR=hazard ratio.
  2. aAdjusted for: age, gender, smoking, BMI, alcohol use and comorbidity (Charlson index).